ALZAMEND NEURO, INC. Interest Expense, Related Party
ALZAMEND NEURO, INC. (ALZN) reported Interest Expense, Related Party of $492.58 thousand for the 9-month period ending 2023-01-31, per its 10-Q filed 2023-03-15.
Discontinued › Expense Statement
us-gaap:InterestExpenseRelatedParty · last filed 2023-03-15
- ALZAMEND NEURO, INC. interest expense, related party for the quarter ending 2023-01-31 was $247.33K.
- ALZAMEND NEURO, INC. interest expense, related party for the quarter ending 2021-04-30 was $2.62K.
- ALZAMEND NEURO, INC. interest expense, related party for the quarter ending 2021-01-31 was $8.28K.
- ALZAMEND NEURO, INC. interest expense, related party for the quarter ending 2020-10-31 was $5.49K.
- ALZAMEND NEURO, INC. interest expense, related party for fiscal 2021 was $16.38K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|
| 2023-01-31 | $247.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-15 | $492.58K 10-Q · filed 2023-03-15 | ||
| 2022-10-31 | $245.25K 10-Q · filed 2022-12-12 | |||
| 2021-04-30 | $2.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-19 | $10.89K derived: sum of 2 quarters · filed 2022-07-19 | $16.38K derived: sum of 3 quarters · filed 2022-07-19 | $16.38K 10-K · filed 2022-07-19 |
| 2021-01-31 | $8.28K 10-Q · filed 2022-03-15 | $13.76K derived: sum of 2 quarters · filed 2022-03-15 | $13.77K 10-Q · filed 2022-03-15 | |
| 2020-10-31 | $5.49K 10-Q · filed 2021-12-13 | $5.49K 10-Q · filed 2021-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |